• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»cryopreserved bone marrow

Is deceased donor marrow a viable backup graft? First human data from Ossium says yes

By Pallavi Madhiraju on January 24, 2026   Pharma & Biotech  

Is deceased donor marrow a viable backup graft? First human data from Ossium says yes

Ossium unveils early data on cryopreserved cadaveric marrow in transplants. Find out what this could mean for urgent graft availability.

Is Ossium Health redefining bone marrow transplants with off-the-shelf cryopreservation?

By Pallavi Madhiraju on January 10, 2026   Pharma & Biotech  

Is Ossium Health redefining bone marrow transplants with off-the-shelf cryopreservation?

Ossium Health’s cryopreserved bone marrow is showing early clinical success. Find out how this could disrupt allogeneic transplantation logistics.

Recent Posts

  • How Codexis, Inc.’s ECO Synthesis platform could reshape industrial RNA production workflows
  • How the PharmAla Biotech Holdings Inc. and Jupiter Neurosciences, Inc. deal reflects changing investor expectations in psychedelics
  • Could Hyundai Bioscience’s XAFTY become a crisis-response antiviral for Ebola and hantavirus?
  • How Araceli Biosciences is pushing live-cell imaging into ultra-high-throughput drug screening
  • Regeneron’s $2.2bn Parabilis pact signals rising interest in next-generation conjugates
  • Samsung Bioepis targets Japan’s autoimmune market with ustekinumab biosimilar debut
  • Bayer’s asundexian FDA priority review puts Factor XIa inhibition closer to a real stroke prevention test
  • Genentech’s ASCO 2026 data puts giredestrant at the centre of Roche’s breast cancer strategy
  • Can Tyvaso change the treatment pathway for idiopathic pulmonary fibrosis after TETON-1?
  • Neurocrine Biosciences strengthens INGREZZA case with functional improvement data
  • Accro Bioscience’s $50m round signals growing interest in targeted IBD immunology
  • Can IBI3002 help Innovent Biologics challenge the next wave of type 2 inflammation therapies?
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes